Medical Care

Global Immunotherapy Drugs Market Research Report 2024

Immunotherapy is a type of cancer treatment that helps your immune system fight cancer. The immune system helps your body fight infections and other diseases. It is made up of white blood cells and organs and tissues of the lymph system.
The global Immunotherapy Drugs market was valued at US$ 193730 million in 2023 and is anticipated to reach US$ 404130 million by 2030, witnessing a CAGR of 10.6% during the forecast period 2024-2030.
North America is expected to account for largest share in the immunotherapy drugs market, by region in 2018. Asia-Pacific is expected to be the fastest-growing regional segment in the market. The high growth of this segment can primarily be attributed to the low cost of manufacturing and acceptable regulatory scenario in this region.
This report aims to provide a comprehensive presentation of the global market for Immunotherapy Drugs, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Immunotherapy Drugs.
Report Scope
The Immunotherapy Drugs market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Immunotherapy Drugs market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Immunotherapy Drugs companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Roche
Merck
Novartis
Johnson & Johnson
Glaxosmithkline
Amgen
Abbvie
Astrazeneca
Bristol-Myers Squibb
ELI Lilly
Segment by Type
Monoclonal Antibodies
Adult Vaccines
Checkpoint Inhibitors
Interferons Alpha & Beta
Interleukins
Others
Segment by Application
Cancer
Autoimmune & Inflammatory Diseases
Infectious Diseases
Others
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Immunotherapy Drugs companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Immunotherapy Drugs Market Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 Monoclonal Antibodies
1.2.3 Adult Vaccines
1.2.4 Checkpoint Inhibitors
1.2.5 Interferons Alpha & Beta
1.2.6 Interleukins
1.2.7 Others
1.3 Market by Application
1.3.1 Global Immunotherapy Drugs Market Growth by Application: 2019 VS 2023 VS 2030
1.3.2 Cancer
1.3.3 Autoimmune & Inflammatory Diseases
1.3.4 Infectious Diseases
1.3.5 Others
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Immunotherapy Drugs Market Perspective (2019-2030)
2.2 Immunotherapy Drugs Growth Trends by Region
2.2.1 Global Immunotherapy Drugs Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 Immunotherapy Drugs Historic Market Size by Region (2019-2024)
2.2.3 Immunotherapy Drugs Forecasted Market Size by Region (2025-2030)
2.3 Immunotherapy Drugs Market Dynamics
2.3.1 Immunotherapy Drugs Industry Trends
2.3.2 Immunotherapy Drugs Market Drivers
2.3.3 Immunotherapy Drugs Market Challenges
2.3.4 Immunotherapy Drugs Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Immunotherapy Drugs Players by Revenue
3.1.1 Global Top Immunotherapy Drugs Players by Revenue (2019-2024)
3.1.2 Global Immunotherapy Drugs Revenue Market Share by Players (2019-2024)
3.2 Global Immunotherapy Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Immunotherapy Drugs Revenue
3.4 Global Immunotherapy Drugs Market Concentration Ratio
3.4.1 Global Immunotherapy Drugs Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Immunotherapy Drugs Revenue in 2023
3.5 Immunotherapy Drugs Key Players Head office and Area Served
3.6 Key Players Immunotherapy Drugs Product Solution and Service
3.7 Date of Enter into Immunotherapy Drugs Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Immunotherapy Drugs Breakdown Data by Type
4.1 Global Immunotherapy Drugs Historic Market Size by Type (2019-2024)
4.2 Global Immunotherapy Drugs Forecasted Market Size by Type (2025-2030)
5 Immunotherapy Drugs Breakdown Data by Application
5.1 Global Immunotherapy Drugs Historic Market Size by Application (2019-2024)
5.2 Global Immunotherapy Drugs Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America Immunotherapy Drugs Market Size (2019-2030)
6.2 North America Immunotherapy Drugs Market Growth Rate by Country: 2019 VS 2023 VS 2030
6.3 North America Immunotherapy Drugs Market Size by Country (2019-2024)
6.4 North America Immunotherapy Drugs Market Size by Country (2025-2030)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Immunotherapy Drugs Market Size (2019-2030)
7.2 Europe Immunotherapy Drugs Market Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 Europe Immunotherapy Drugs Market Size by Country (2019-2024)
7.4 Europe Immunotherapy Drugs Market Size by Country (2025-2030)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Immunotherapy Drugs Market Size (2019-2030)
8.2 Asia-Pacific Immunotherapy Drugs Market Growth Rate by Region: 2019 VS 2023 VS 2030
8.3 Asia-Pacific Immunotherapy Drugs Market Size by Region (2019-2024)
8.4 Asia-Pacific Immunotherapy Drugs Market Size by Region (2025-2030)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Immunotherapy Drugs Market Size (2019-2030)
9.2 Latin America Immunotherapy Drugs Market Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Latin America Immunotherapy Drugs Market Size by Country (2019-2024)
9.4 Latin America Immunotherapy Drugs Market Size by Country (2025-2030)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Immunotherapy Drugs Market Size (2019-2030)
10.2 Middle East & Africa Immunotherapy Drugs Market Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Middle East & Africa Immunotherapy Drugs Market Size by Country (2019-2024)
10.4 Middle East & Africa Immunotherapy Drugs Market Size by Country (2025-2030)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Roche
11.1.1 Roche Company Detail
11.1.2 Roche Business Overview
11.1.3 Roche Immunotherapy Drugs Introduction
11.1.4 Roche Revenue in Immunotherapy Drugs Business (2019-2024)
11.1.5 Roche Recent Development
11.2 Merck
11.2.1 Merck Company Detail
11.2.2 Merck Business Overview
11.2.3 Merck Immunotherapy Drugs Introduction
11.2.4 Merck Revenue in Immunotherapy Drugs Business (2019-2024)
11.2.5 Merck Recent Development
11.3 Novartis
11.3.1 Novartis Company Detail
11.3.2 Novartis Business Overview
11.3.3 Novartis Immunotherapy Drugs Introduction
11.3.4 Novartis Revenue in Immunotherapy Drugs Business (2019-2024)
11.3.5 Novartis Recent Development
11.4 Johnson & Johnson
11.4.1 Johnson & Johnson Company Detail
11.4.2 Johnson & Johnson Business Overview
11.4.3 Johnson & Johnson Immunotherapy Drugs Introduction
11.4.4 Johnson & Johnson Revenue in Immunotherapy Drugs Business (2019-2024)
11.4.5 Johnson & Johnson Recent Development
11.5 Glaxosmithkline
11.5.1 Glaxosmithkline Company Detail
11.5.2 Glaxosmithkline Business Overview
11.5.3 Glaxosmithkline Immunotherapy Drugs Introduction
11.5.4 Glaxosmithkline Revenue in Immunotherapy Drugs Business (2019-2024)
11.5.5 Glaxosmithkline Recent Development
11.6 Amgen
11.6.1 Amgen Company Detail
11.6.2 Amgen Business Overview
11.6.3 Amgen Immunotherapy Drugs Introduction
11.6.4 Amgen Revenue in Immunotherapy Drugs Business (2019-2024)
11.6.5 Amgen Recent Development
11.7 Abbvie
11.7.1 Abbvie Company Detail
11.7.2 Abbvie Business Overview
11.7.3 Abbvie Immunotherapy Drugs Introduction
11.7.4 Abbvie Revenue in Immunotherapy Drugs Business (2019-2024)
11.7.5 Abbvie Recent Development
11.8 Astrazeneca
11.8.1 Astrazeneca Company Detail
11.8.2 Astrazeneca Business Overview
11.8.3 Astrazeneca Immunotherapy Drugs Introduction
11.8.4 Astrazeneca Revenue in Immunotherapy Drugs Business (2019-2024)
11.8.5 Astrazeneca Recent Development
11.9 Bristol-Myers Squibb
11.9.1 Bristol-Myers Squibb Company Detail
11.9.2 Bristol-Myers Squibb Business Overview
11.9.3 Bristol-Myers Squibb Immunotherapy Drugs Introduction
11.9.4 Bristol-Myers Squibb Revenue in Immunotherapy Drugs Business (2019-2024)
11.9.5 Bristol-Myers Squibb Recent Development
11.10 ELI Lilly
11.10.1 ELI Lilly Company Detail
11.10.2 ELI Lilly Business Overview
11.10.3 ELI Lilly Immunotherapy Drugs Introduction
11.10.4 ELI Lilly Revenue in Immunotherapy Drugs Business (2019-2024)
11.10.5 ELI Lilly Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
List of Tables
Table 1. Global Immunotherapy Drugs Market Size Growth Rate by Type (US$ Million): 2019 VS 2023 VS 2030
Table 2. Key Players of Monoclonal Antibodies
Table 3. Key Players of Adult Vaccines
Table 4. Key Players of Checkpoint Inhibitors
Table 5. Key Players of Interferons Alpha & Beta
Table 6. Key Players of Interleukins
Table 7. Key Players of Others
Table 8. Global Immunotherapy Drugs Market Size Growth by Application (US$ Million): 2019 VS 2023 VS 2030
Table 9. Global Immunotherapy Drugs Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Table 10. Global Immunotherapy Drugs Market Size by Region (2019-2024) & (US$ Million)
Table 11. Global Immunotherapy Drugs Market Share by Region (2019-2024)
Table 12. Global Immunotherapy Drugs Forecasted Market Size by Region (2025-2030) & (US$ Million)
Table 13. Global Immunotherapy Drugs Market Share by Region (2025-2030)
Table 14. Immunotherapy Drugs Market Trends
Table 15. Immunotherapy Drugs Market Drivers
Table 16. Immunotherapy Drugs Market Challenges
Table 17. Immunotherapy Drugs Market Restraints
Table 18. Global Immunotherapy Drugs Revenue by Players (2019-2024) & (US$ Million)
Table 19. Global Immunotherapy Drugs Market Share by Players (2019-2024)
Table 20. Global Top Immunotherapy Drugs Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Immunotherapy Drugs as of 2023)
Table 21. Ranking of Global Top Immunotherapy Drugs Companies by Revenue (US$ Million) in 2023
Table 22. Global 5 Largest Players Market Share by Immunotherapy Drugs Revenue (CR5 and HHI) & (2019-2024)
Table 23. Key Players Headquarters and Area Served
Table 24. Key Players Immunotherapy Drugs Product Solution and Service
Table 25. Date of Enter into Immunotherapy Drugs Market
Table 26. Mergers & Acquisitions, Expansion Plans
Table 27. Global Immunotherapy Drugs Market Size by Type (2019-2024) & (US$ Million)
Table 28. Global Immunotherapy Drugs Revenue Market Share by Type (2019-2024)
Table 29. Global Immunotherapy Drugs Forecasted Market Size by Type (2025-2030) & (US$ Million)
Table 30. Global Immunotherapy Drugs Revenue Market Share by Type (2025-2030)
Table 31. Global Immunotherapy Drugs Market Size by Application (2019-2024) & (US$ Million)
Table 32. Global Immunotherapy Drugs Revenue Market Share by Application (2019-2024)
Table 33. Global Immunotherapy Drugs Forecasted Market Size by Application (2025-2030) & (US$ Million)
Table 34. Global Immunotherapy Drugs Revenue Market Share by Application (2025-2030)
Table 35. North America Immunotherapy Drugs Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 36. North America Immunotherapy Drugs Market Size by Country (2019-2024) & (US$ Million)
Table 37. North America Immunotherapy Drugs Market Size by Country (2025-2030) & (US$ Million)
Table 38. Europe Immunotherapy Drugs Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 39. Europe Immunotherapy Drugs Market Size by Country (2019-2024) & (US$ Million)
Table 40. Europe Immunotherapy Drugs Market Size by Country (2025-2030) & (US$ Million)
Table 41. Asia-Pacific Immunotherapy Drugs Market Size Growth Rate by Region (US$ Million): 2019 VS 2023 VS 2030
Table 42. Asia-Pacific Immunotherapy Drugs Market Size by Region (2019-2024) & (US$ Million)
Table 43. Asia-Pacific Immunotherapy Drugs Market Size by Region (2025-2030) & (US$ Million)
Table 44. Latin America Immunotherapy Drugs Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 45. Latin America Immunotherapy Drugs Market Size by Country (2019-2024) & (US$ Million)
Table 46. Latin America Immunotherapy Drugs Market Size by Country (2025-2030) & (US$ Million)
Table 47. Middle East & Africa Immunotherapy Drugs Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 48. Middle East & Africa Immunotherapy Drugs Market Size by Country (2019-2024) & (US$ Million)
Table 49. Middle East & Africa Immunotherapy Drugs Market Size by Country (2025-2030) & (US$ Million)
Table 50. Roche Company Detail
Table 51. Roche Business Overview
Table 52. Roche Immunotherapy Drugs Product
Table 53. Roche Revenue in Immunotherapy Drugs Business (2019-2024) & (US$ Million)
Table 54. Roche Recent Development
Table 55. Merck Company Detail
Table 56. Merck Business Overview
Table 57. Merck Immunotherapy Drugs Product
Table 58. Merck Revenue in Immunotherapy Drugs Business (2019-2024) & (US$ Million)
Table 59. Merck Recent Development
Table 60. Novartis Company Detail
Table 61. Novartis Business Overview
Table 62. Novartis Immunotherapy Drugs Product
Table 63. Novartis Revenue in Immunotherapy Drugs Business (2019-2024) & (US$ Million)
Table 64. Novartis Recent Development
Table 65. Johnson & Johnson Company Detail
Table 66. Johnson & Johnson Business Overview
Table 67. Johnson & Johnson Immunotherapy Drugs Product
Table 68. Johnson & Johnson Revenue in Immunotherapy Drugs Business (2019-2024) & (US$ Million)
Table 69. Johnson & Johnson Recent Development
Table 70. Glaxosmithkline Company Detail
Table 71. Glaxosmithkline Business Overview
Table 72. Glaxosmithkline Immunotherapy Drugs Product
Table 73. Glaxosmithkline Revenue in Immunotherapy Drugs Business (2019-2024) & (US$ Million)
Table 74. Glaxosmithkline Recent Development
Table 75. Amgen Company Detail
Table 76. Amgen Business Overview
Table 77. Amgen Immunotherapy Drugs Product
Table 78. Amgen Revenue in Immunotherapy Drugs Business (2019-2024) & (US$ Million)
Table 79. Amgen Recent Development
Table 80. Abbvie Company Detail
Table 81. Abbvie Business Overview
Table 82. Abbvie Immunotherapy Drugs Product
Table 83. Abbvie Revenue in Immunotherapy Drugs Business (2019-2024) & (US$ Million)
Table 84. Abbvie Recent Development
Table 85. Astrazeneca Company Detail
Table 86. Astrazeneca Business Overview
Table 87. Astrazeneca Immunotherapy Drugs Product
Table 88. Astrazeneca Revenue in Immunotherapy Drugs Business (2019-2024) & (US$ Million)
Table 89. Astrazeneca Recent Development
Table 90. Bristol-Myers Squibb Company Detail
Table 91. Bristol-Myers Squibb Business Overview
Table 92. Bristol-Myers Squibb Immunotherapy Drugs Product
Table 93. Bristol-Myers Squibb Revenue in Immunotherapy Drugs Business (2019-2024) & (US$ Million)
Table 94. Bristol-Myers Squibb Recent Development
Table 95. ELI Lilly Company Detail
Table 96. ELI Lilly Business Overview
Table 97. ELI Lilly Immunotherapy Drugs Product
Table 98. ELI Lilly Revenue in Immunotherapy Drugs Business (2019-2024) & (US$ Million)
Table 99. ELI Lilly Recent Development
Table 100. Research Programs/Design for This Report
Table 101. Key Data Information from Secondary Sources
Table 102. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Immunotherapy Drugs Market Size Comparison by Type (2024-2030) & (US$ Million)
Figure 2. Global Immunotherapy Drugs Market Share by Type: 2023 VS 2030
Figure 3. Monoclonal Antibodies Features
Figure 4. Adult Vaccines Features
Figure 5. Checkpoint Inhibitors Features
Figure 6. Interferons Alpha & Beta Features
Figure 7. Interleukins Features
Figure 8. Others Features
Figure 9. Global Immunotherapy Drugs Market Size Comparison by Application (2024-2030) & (US$ Million)
Figure 10. Global Immunotherapy Drugs Market Share by Application: 2023 VS 2030
Figure 11. Cancer Case Studies
Figure 12. Autoimmune & Inflammatory Diseases Case Studies
Figure 13. Infectious Diseases Case Studies
Figure 14. Others Case Studies
Figure 15. Immunotherapy Drugs Report Years Considered
Figure 16. Global Immunotherapy Drugs Market Size (US$ Million), Year-over-Year: 2019-2030
Figure 17. Global Immunotherapy Drugs Market Size, (US$ Million), 2019 VS 2023 VS 2030
Figure 18. Global Immunotherapy Drugs Market Share by Region: 2023 VS 2030
Figure 19. Global Immunotherapy Drugs Market Share by Players in 2023
Figure 20. Global Top Immunotherapy Drugs Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Immunotherapy Drugs as of 2023)
Figure 21. The Top 10 and 5 Players Market Share by Immunotherapy Drugs Revenue in 2023
Figure 22. North America Immunotherapy Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 23. North America Immunotherapy Drugs Market Share by Country (2019-2030)
Figure 24. United States Immunotherapy Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 25. Canada Immunotherapy Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 26. Europe Immunotherapy Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 27. Europe Immunotherapy Drugs Market Share by Country (2019-2030)
Figure 28. Germany Immunotherapy Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 29. France Immunotherapy Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 30. U.K. Immunotherapy Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 31. Italy Immunotherapy Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 32. Russia Immunotherapy Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 33. Nordic Countries Immunotherapy Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 34. Asia-Pacific Immunotherapy Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 35. Asia-Pacific Immunotherapy Drugs Market Share by Region (2019-2030)
Figure 36. China Immunotherapy Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 37. Japan Immunotherapy Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 38. South Korea Immunotherapy Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 39. Southeast Asia Immunotherapy Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 40. India Immunotherapy Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 41. Australia Immunotherapy Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 42. Latin America Immunotherapy Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 43. Latin America Immunotherapy Drugs Market Share by Country (2019-2030)
Figure 44. Mexico Immunotherapy Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 45. Brazil Immunotherapy Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 46. Middle East & Africa Immunotherapy Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 47. Middle East & Africa Immunotherapy Drugs Market Share by Country (2019-2030)
Figure 48. Turkey Immunotherapy Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 49. Saudi Arabia Immunotherapy Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 50. Roche Revenue Growth Rate in Immunotherapy Drugs Business (2019-2024)
Figure 51. Merck Revenue Growth Rate in Immunotherapy Drugs Business (2019-2024)
Figure 52. Novartis Revenue Growth Rate in Immunotherapy Drugs Business (2019-2024)
Figure 53. Johnson & Johnson Revenue Growth Rate in Immunotherapy Drugs Business (2019-2024)
Figure 54. Glaxosmithkline Revenue Growth Rate in Immunotherapy Drugs Business (2019-2024)
Figure 55. Amgen Revenue Growth Rate in Immunotherapy Drugs Business (2019-2024)
Figure 56. Abbvie Revenue Growth Rate in Immunotherapy Drugs Business (2019-2024)
Figure 57. Astrazeneca Revenue Growth Rate in Immunotherapy Drugs Business (2019-2024)
Figure 58. Bristol-Myers Squibb Revenue Growth Rate in Immunotherapy Drugs Business (2019-2024)
Figure 59. ELI Lilly Revenue Growth Rate in Immunotherapy Drugs Business (2019-2024)
Figure 60. Bottom-up and Top-down Approaches for This Report
Figure 61. Data Triangulation
Figure 62. Key Executives Interviewed
Choose Your Edition
Add to cart

Our team would be happy to assist you with your queries.

Contact us

About us

Accurate data, The latest market trends, And deeper research directions.

Our sole purpose is to provide a basis for leaders in all walks of life to make more appropriate decisions, to help companies solve existing problems and achieve business goals

Latest reports

Useful links

Our Contacts

Room 2306, T6 Fuxing World Financial Center, Kaifu District, Changsha, Hunan, China

(+86) 159 1069 5232

sales@hengceresearch.com
hengceresearch.com

Allow cookies